Molecular, genetic and epigenetic pathways of peroxynitrite-induced cellular toxicity
By: Ahmet Korkmaz, Sukru Oter, Melik Seyrek and Turgut Topal
Open Access
|Jan 2010References
- Adcock IM, Ito K, Barnes PJ. (2004). Glucocorticoids: effects on gene transcription.: 247-54.
- Aitio ML. (2006). N-acetylcysteine - passe-partout or much ado about nothing?: 5-15.
- Alvarez B, Radi R. (2001). Peroxynitrite decay in the presence of hydrogen peroxide, mannitol and ethanol: a reappraisal.: 467-75.
- Alvarez B, Radi R. (2003). Peroxynitrite reactivity with amino acids and proteins.:: 295-311.
- Ascherio A, Rimm EB, Hernan MA, Giovannucci E, Kawachi I, Stampfer MJ, Willett WC. (1999). Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States.: 963-70.
- Barnes PJ. (2006). How corticosteroids control inflammation: Quintiles Prize Lecture 2005.: 245-54.
- Barnes PJ, Ito K, Adcock IM. (2004). Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.: 731-3.
- Beckman JS, Koppenol WH. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.: C1424-37.
- Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.: 842-57.
- Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. (2004). Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis.: 1219-28.
- Black PN, Morgan-Day A, McMillan TE, Poole PJ, Young RP. (2004). Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344].: 13.
- Boman G, Backer U, Larsson S, Melander B, Wahlander L. (1983). Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.: 405-15.
- Bombail V, Moggs JG, Orphanides G. (2004). Perturbation of epigenetic status by toxicants.: 51-8.
- Campbell KJ, Rocha S, Perkins ND. (2004). Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B.: 853-65.
- Ceriello A. (2006). Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes.: 510-8.
- Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuller JH. (1998). Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.: 28-31.
- Chen LF, Greene WC. (2003). Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation.: 549-57.
- Chien YH, Bau DT, Jan KY. (2004). Nitric oxide inhibits DNA-adduct excision in nucleotide excision repair.: 1011-7.
- Cooke CL, Davidge ST. (2002). Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells.: C395-402.
- Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. (1999). Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.: 1635-9.
- Dai Y, Rahmani M, Grant S. (2003). An intact NF-kappaB pathway is required for histone deacetylase inhibitor-induced G1 arrest and maturation in U937 human myeloid leukemia cells.: 467-72.
- de Grey AD. (2006). Free radicals in aging: causal complexity and its biomedical implications.: 1244-9.
- de la Lastra CA, Villegas I, Sanchez-Fidalgo S. (2007). Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications.: 933-62.
- Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W. (2005). Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial.: 1552-60.
- Dedon PC, Tannenbaum SR. (2004). Reactive nitrogen species in the chemical biology of inflammation.: 12-22.
- Demicheli V, Quijano C, Alvarez B, Radi R. (2007). Inactivation and nitration of human superoxide dismutase (SOD) by fluxes of nitric oxide and superoxide.: 1359-68.
- Forstermann U, Munzel T. (2006). Endothelial nitric oxide synthase in vascular disease: from marvel to menace.: 1708-14.
- Gallou-Kabani C, Junien C. (2005). Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic.: 1899-906.
- Graham B, Gibson SB. (2005). The two faces of NFkappaB in cell survival responses.: 1342-5.
- Hageman GJ, Larik I, Pennings HJ, Haenen GR, Wouters EF, Bast A. (2003). Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients.: 140-8.
- Harman D. (2003). The free radical theory of aging.: 557-61.
- Harman D. (2006). Free radical theory of aging: an update: increasing the functional life span.: 10-21.
- Herbert V. (1994). The antioxidant supplement myth.: 157-8.
- Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO. (2004). The nature of small-airway obstruction in chronic obstructive pulmonary disease.: 2645-53.
- Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IM. (2004). Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration.: 240-5.
- Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC. (2005). Decreased histone deacetylase activity in chronic obstructive pulmonary disease.: 1967-76.
- Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM. (2001). Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages.: 1110-2.
- Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ and Adcock IM. (2006). Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression.: 7-13.
- Jiang YH, Bressler J, Beaud. (2004). Epigenetics and human disease.: 479-510.
- Joshi MS, Ferguson TB Jr, Han TH, Hyduke DR, Liao JC, Rassaf T, Bryan N, Feelisch M, Lancaster JR Jr. (2002). Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions.: 10341-6.
- Juedes MJ, Wogan GN. (1996). Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells.: 51-61.
- Kiningham KK, Xu Y, Daosukho C, Popova B, St Clair DK. (2001). Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2.: 147-156.
- Kirkham P, Rahman I. (2006). Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.: 476-94.
- Korkmaz A, Kurt B, Yildirim I, Basal S, Topal T, Sadir S, Oter S. (2008a). Effects of Poly(ADP-Ribose) Polymerase Inhibition in Bladder Damage Caused by Cyclophosphamide in Rats.: 338-43.
- Korkmaz A, Oter S, Sadir S, Coskun O, Topal T, Ozler M, Bilgic H. (2005). Peroxynitrite may be involved in bladder damage caused by cyclophosphamide in rats.: 1793-6.
- Korkmaz A, Topal T, Oter S. (2007). Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation.: 303-12.
- Korkmaz A, Topal T, Oter S, Tan DX, Reiter RJ. (2008b). Hyperglycemia-related pathophysiologic mechanisms and potential beneficial actions of melatonin.: 1144-53.
- Korkmaz A, Yaren H, Topal T, Oter S. (2006). Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation.: 662-70.
- Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A, Leitzmann MF. (2007). Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study.: 754-64.
- Levrand S, Vannay-Bouchiche C, Pesse B, Pacher P, Feihl F, Waeber B, Liaudet L. (2006). Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo.: 886-95.
- Linnane AW, Kios M, Vitetta L. (2007). The essential requirement for superoxide radical and nitric oxide formation for normal physiological function and healthy aging.: 1-5.
- Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC. (2002). Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.: 1919-27.
- Loppow D, Schleiss MB, Kanniess F, Taube C, Jorres RA, Magnussen H. (2001). In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation.: 115-21.
- Marwick JA, Kirkham PA, Stevenson CS, Danahay H, Giddings J, Butler K, Donaldson K, Macnee W, Rahman I. (2004). Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs.: 633-42.
- Masuda M, Nishino H, Ohshima H. (2002). Formation of 8-nitroguanosine in cellular RNA as a biomarker of exposure to reactive nitrogen species.: 187-97.
- Mattson MP, Culmsee C, Yu Z, Camandola S. (2000). Roles of nuclear factor kappaB in neuronal survival and plasticity.: 443-56.
- McLachlan JA. (2001). Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals.: 319-41.
- McLachlan JA, Burow M, Chiang TC, Li SF. (2001). Gene imprinting in developmental toxicology: a possible interface between physiology and pathology.: 161-4.
- Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. (2005). Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.: 37-46.
- Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C. (2007). Cancer genetics of epigenetic genes.: R28-49.
- Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D. (2005). Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors.: 217-52.
- Moncada S, Palmer RM, Higgs EA. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology.: 109-42.
- Moodie FM, Marwick JA, Anderson CS, Szulakowski P, Biswas SK, Bauter MR, Kilty I, Rahman I. (2004). Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells.: 1897-9.
- Moretti M, Marchioni CF. (2007). An overview of erdosteine antioxidant activity in experimental research.: 249-54.
- Mroz RM, Noparlik J, Chyczewska E, Braszko JJ, Holownia A. (2007). Molecular basis of chronic inflammation in lung diseases: new therapeutic approach.: 453-60.
- Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM. (2002). Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality.: 1472-6.
- Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. (2001). Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation.: 29596-602.
- Pacher P, Beckman JS, Liaudet L. (2007). Nitric oxide and peroxynitrite in health and disease.: 315-424.
- Pela R, Calcagni AM, Subiaco S, Isidori P, Tubaldi A, Sanguinetti CM. (1999). N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD.: 495-500.
- Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ. (1997). Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator.: 523-7.
- Poli G, Parola M. (1997). Oxidative damage and fibrogenesis.: 287-305.
- Rahman I, MacNee W. (1996). Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease.: 348-50.
- Rahman I, Marwick J, Kirkham P. (2004). Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression.: 1255-67.
- Rasmussen JB, Glennow C. (1988). Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis.: 351-5.
- Riccioni G, Barbara M, Bucciarelli T, di Ilio C, D'Orazio N. (2007). Antioxidant vitamin supplementation in asthma.: 96-101.
- Roy S, Packman K, Jeffrey R, Tenniswood M. (2005). Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.: 482-91.
- Salganik RI. (2001). The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population.: 464S-472S; discussion 473S-475S.
- Slatore CG, Littman AJ, Au DH, Satia JA, White E. (2008). Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer.: 524-30.
- Song YS, Lee YS, Chan PH. (2005). Oxidative stress transiently decreases the IKK complex (IKK alpha, beta, and gamma), an upstream component of NF-kappaB signaling, after transient focal cerebral ischemia in mice.: 1301-11.
- Song YS, Lee YS, Narasimhan P, Chan PH. (2007). Reduced oxidative stress promotes NF-kappaB-mediated neuroprotective gene expression after transient focal cerebral ischemia: lymphocytotrophic cytokines and antiapoptotic factors.: 764-75.
- Stockklauser-Farber K, Ballhausen T, Laufer A, Rosen P. (2000). Influence of diabetes on cardiac nitric oxide synthase expression and activity.: 10-20.
- Sun Y, Oberley LW. (1996). Redox regulation of transcriptional activators.: 335-48.
- Szabo C. (2003). Multiple pathways of peroxynitrite cytotoxicity.: 105-12.
- Szabo C. (2006). Poly(ADP-ribose) polymerase activation by reactive nitrogen species-relevance for the pathogenesis of inflammation.: 169-79.
- Tamir S, deRojas-Walker T, Wishnok JS, Tannenbaum SR. (1996). DNA damage and genotoxicity by nitric oxide.: 230-43.
- Virag L, Szabo E, Gergely P, Szabo C. (2003). Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention.: 113-24.
- Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. (2003). Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.: 2017-23.
- Wallaert B, Lassalle P, Fortin F, Aerts C, Bart F, Fournier E, Voisin C. (1990). Superoxide anion generation by alveolar inflammatory cells in simple pneumoconiosis and in progressive massive fibrosis of nonsmoking coal workers.: 129-33.
- Wang T, Zhang X, Li JJ. (2002). The role of NF-kappaB in the regulation of cell stress responses.: 1509-20.
- Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD, Hodgson JM. (2007). The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.: 227-34.
- Weidig P, McMaster D, Bayraktutan U. (2004). High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells.: 432-41.
- Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL. (1998). Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.: 5246-50.
- Woo JJ. (2007). Adverse event monitoring and multivitamin-multimineral dietary supplements.: 323S-324S.
- Wu J, Akaike T, Hayashida K, Okamoto T, Okuyama A, Maeda H. (2001). Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases.: 439-51.
- Xu Y, Kiningham KK, Devalaraja MN, Yeh CC, Majima H, Kasarskis EJ, St Clair DK. (1999). An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta.: 709-22.
- Yaren H, Mollaoglu H, Kurt B, Korkmaz A, Oter S, Topal T, Karayilanoglu T. (2007). Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats.: 116-22.
- Yermilov V, Yoshie Y, Rubio J, Ohshima H. (1996). Effects of carbon dioxide/bicarbonate on induction of DNA single-strand breaks and formation of 8-nitroguanine, 8-oxoguanine and base-propenal mediated by peroxynitrite.: 67-70.
- Yoshie Y, Ohshima H. (1997). Nitric oxide synergistically enhances DNA strand breakage induced by polyhydroxyaromatic compounds, but inhibits that induced by the Fenton reaction.: 13-21.
Language: English
Page range: 219 - 228
Published on: Jan 6, 2010
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Related subjects:
© 2010 Ahmet Korkmaz, Sukru Oter, Melik Seyrek, Turgut Topal, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.